Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

American Express Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Published 26/01/2024, 07:38
© Reuters. American Express Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

American Express Company (NYSE: AXP) is expected to release earnings results for its fourth quarter, before the opening bell on Jan. 26, 2024.

Analysts expect the company to report quarterly earnings at $2.64 per share, up from year-ago earnings of $2.07 per share. The company is projected to report revenue of $16 billion, compared to $14.18 billion in the year-earlier quarter, according to data from Benzinga Pro.

American Express, during October, said third-quarter revenue (net of interest expense) grew 12% year-on-year to $15.38 billion, beating the consensus of $15.36 billion. EPS of $3.30 beat the consensus of $2.94.

American Express shares gained 1.2% to close at $188.07 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Baird analyst David George downgraded the stock from Neutral to Underperform with a price target of $190 on Jan. 8, 2024. This analyst has an accuracy rate of 75%.
  • JP Morgan analyst Richard Shane upgraded the stock from Neutral to Overweight and increased the price target from $167 to $205 on Jan. 4, 2024. This analyst has an accuracy rate of 68%.
  • Citigroup analyst Arren Cyganovich upgraded the stock from Sell to Neutral and raised the price target from $143 to $154 on Oct. 25, 2023. This analyst has an accuracy rate of 75%.
  • Piper Sandler analyst Kevin Barker upgraded the stock from Underweight to Neutral and increased the price target from $150 to $151 on Oct. 24, 2023. This analyst has an accuracy rate of 74%.
  • RBC Capital analyst Jon Arfstrom maintained an Outperform rating and cut the price target from $190 to $185 on Oct. 23, 2023. This analyst has an accuracy rate of 76%.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read This Next: Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month

Latest Ratings for AXP

Feb 2022Daiwa CapitalUpgradesHoldBuy
Feb 2022Morgan StanleyMaintainsOverweight
Jan 2022Deutsche BankMaintainsBuy

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.